IMVT - Company ID 0001764013
As of 2026-09-07, Immunovant, Inc. (IMVT) has a market capitalization of $8.06 B, making it the #1089 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-09-07 | $8.06 B |
| 2026-09-06 | $8.06 B |
| 2026-09-05 | $8.06 B |
| 2026-09-04 | $8.06 B |
| 2026-09-03 | $8.11 B |
| 2026-09-02 | $8.11 B |
| 2026-09-01 | $8.19 B |
| 2026-08-31 | $8.38 B |
| 2026-08-30 | $8.46 B |
| 2026-08-29 | $8.46 B |
| 2026-08-28 | $8.51 B |
| 2026-08-27 | $9.00 B |
As of 2026-09-07, Immunovant, Inc. (IMVT) has a market capitalization of $8.06 B, making it the #1089 most valuable US-listed company.
Immunovant, Inc. is the #1089 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-08-26 | $9.01 B |
| 2026-08-25 | $8.92 B |
| 2026-08-24 | $8.89 B |
| 2026-08-23 | $9.11 B |
| 2026-08-22 | $9.11 B |
| 2026-08-21 | $9.11 B |
| 2026-08-20 | $9.11 B |
| 2026-08-19 | $9.23 B |
| 2026-08-18 | $8.89 B |
| 2026-08-17 | $8.97 B |
| 2026-08-16 | $8.59 B |
| 2026-08-15 | $8.59 B |
| 2026-08-14 | $8.56 B |
| 2026-08-13 | $8.59 B |
| 2026-08-12 | $8.75 B |
| 2026-08-11 | $8.40 B |
| 2026-08-10 | $8.16 B |
| 2026-08-09 | $8.20 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.